Brian Robert Lane, PT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 8701 Cuyamaca St, Santee, CA 92071 Phone: 619-568-8105 |
Daniel Strauss, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 10538 Mission Gorge Rd Ste 120, Santee, CA 92071 Phone: 619-312-6109 Fax: 619-312-6110 |
News Archive
Boehringer Ingelheim announced today that the US Food and Drug Administration (FDA) has approved a new indication for MICARDIS® (telmisartan) for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors. MICARDIS® is the first treatment in its class to be approved for this indication.
Community based digital eye screening programme designed to detect and treat diabetic retinopathy, the leading cause of blindness in the developed world, is being rolled out to other locations, following its huge success since launching seven months ago.
Infants with various forms of congenital heart disease require a stable source of blood flow to their lungs in order to survive until a more definitive operation can be performed. In a recent study, pediatric researchers compared two methods to provide that flow: a shunt to reroute blood and an implanted stent to maintain an open path for blood flow.
A study in the Feb. 1 issue of the journal SLEEP found gray matter concentration deficits in multiple brain areas of people with severe obstructive sleep apnea (OSA). The study suggests that the memory impairment, cardiovascular disturbances, executive dysfunctions, and dysregulation of autonomic and respiratory control frequently observed in OSA patients may be related to morphological changes in brain structure.
› Verified 8 days ago